CRYDER CAPITAL PARTNERS LLP Holdings
CRYDER CAPITAL PARTNERS LLP is an investment fund managing more than 1.61B US dollars. The largest holdings include Thermo Fisher Scientific, HCA Healthcare and Microsoft. In Q3 2022 the fund bought assets of total value of -108.09M US dollars and sold assets of total value of 111.96M US dollars.
CRYDER CAPITAL PARTNERS LLP portfolio value:
CRYDER CAPITAL PARTNERS LLP quarter portfolio value change:
CRYDER CAPITAL PARTNERS LLP 1 year portfolio value change:
CRYDER CAPITAL PARTNERS LLP 3 years portfolio value change:
CRYDER CAPITAL PARTNERS LLP 5 years portfolio value change:
CRYDER CAPITAL PARTNERS LLP portfolio changes
Period | Buy | Sel |
---|---|---|
Q1 2016 | 40284000 | 28698000 |
Q2 2016 | 12606000 | 18633000 |
Q4 2016 | 74963000 | 21630000 |
Q1 2017 | 2568000 | 4555000 |
Q2 2017 | 18402000 | 12419000 |
Q3 2017 | -2595000 | 34059000 |
Q3 2018 | 17933000 | 19950000 |
Q4 2018 | -23717000 | 51512000 |
Q2 2019 | 24797000 | 3785000 |
Q3 2019 | 215615000 | 112769000 |
Q1 2020 | -9914000 | 185951000 |
Q4 2020 | 203354000 | 26853000 |
Q1 2021 | 108063000 | 39254000 |
Q3 2021 | 19597000 | 2831000 |
Q1 2022 | -145125000 | 28333000 |
Q3 2022 | -108092000 | 111963000 |
CRYDER CAPITAL PARTNERS LLP 13F holdings
Stock |
---|
Portfolio share: 13.61% Portfolio value: 219.37M Avg. open price: $289.6 Current price: $563 P/L: +94.40% Sold -0.09% shares Q3 2022 |
Portfolio share: 12.76% Portfolio value: 205.62M Avg. open price: $118.66 Current price: $239.03 P/L: +101.45% Sold -0.12% shares Q3 2022 |
Portfolio share: 12.71% Portfolio value: 204.90M Avg. open price: $263.62 Current price: $255.02 P/L: -3.26% Sold -0.10% shares Q3 2022 |
Portfolio share: 12.28% Portfolio value: 197.87M Avg. open price: $1,708.25 Current price: $100.83 P/L: -94.10% Sold -0.10% shares Q3 2022 |
Portfolio share: 11.53% Portfolio value: 185.86M Avg. open price: $74.14 Current price: $85.16 P/L: +14.87% Sold -0.15% shares Q3 2022 |
Portfolio share: 10.82% Portfolio value: 174.47M Avg. open price: $585.18 Current price: $392.69 P/L: -32.89% Bought +11.25% shares Q3 2022 |
Portfolio share: 8.55% Portfolio value: 137.75M Avg. open price: $222.36 Current price: $123.49 P/L: -44.46% Sold -0.28% shares Q3 2022 |
Portfolio share: 6.76% Portfolio value: 108.98M Avg. open price: $156.07 Current price: $217.66 P/L: +39.46% Sold -0.29% shares Q3 2022 |
Portfolio share: 6.00% Portfolio value: 96.76M Avg. open price: $205.14 Current price: $90.06 P/L: -56.10% Bought +0.30% shares Q3 2022 |
Portfolio share: 4.98% Portfolio value: 80.29M Avg. open price: $203.58 Current price: $360.06 P/L: +76.87% Sold -0.44% shares Q3 2022 |
Showing TOP 10 CRYDER CAPITAL PARTNERS LLP's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of CRYDER CAPITAL PARTNERS LLP?
The biggest position of the CRYDER CAPITAL PARTNERS LLP is Thermo Fisher Scientific Inc. (TMO) with 13.61% portfolio share worth of 219.37M US dollars.
Top 5 CRYDER CAPITAL PARTNERS LLP's holdings represent 62.88% of the portfolio:
- Thermo Fisher Scientific Inc. (TMO) – 13.61%
- HCA Healthcare, Inc. (HCA) – 12.76%
- Microsoft Corporation (MSFT) – 12.71%
- Alphabet Inc. (GOOG) – 12.28%
- Blackstone Inc. (BX) – 11.53%
Who is the portfolio manager of CRYDER CAPITAL PARTNERS LLP?
The portfolio manager of the CRYDER CAPITAL PARTNERS LLP is .
What is the total asset value of the CRYDER CAPITAL PARTNERS LLP portfolio?
CRYDER CAPITAL PARTNERS LLP total asset value (portfolio value) is 1.61B US dollars.
Who is ?
is the portfolio manager of the CRYDER CAPITAL PARTNERS LLP.
What is (CRYDER CAPITAL PARTNERS LLP) fund performance?
CRYDER CAPITAL PARTNERS LLP's quarterly performance is -73.89%, annualy -309.13%. In the past 3 years, the value of 's portfolio has decreased by -709%. In the past 5 years, the value of the portfolio has decreased by -2248%.
What is the CRYDER CAPITAL PARTNERS LLP CIK?
CRYDER CAPITAL PARTNERS LLP's Central Index Key is 0001633969 .